Kalypsys
Shaping the future of medicine through comprehensive, automated drug discovery and development services across multiple therapeutic areas.
est. 2001
Recursion
Decoding Biology to Radically Improve Lives
770 employees · est. 2013 · Salt Lake City, United State...
Kalypsys is the older company (2001 vs 2013).
Side-by-Side Comparison
| Metric | Kalypsys | Recursion |
|---|---|---|
| Founded | ||
| Founded | 2001 older | 2013 |
| Headquarters | ||
| Headquarters | Not tracked yet | Salt Lake City, United States |
| Employees | ||
| Employees | Not tracked yet | 770 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness | AI, Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series C | IPO |
| Total Funding | ||
| Total Funding | $171.00M | $1.30B |
| Funding Rounds | ||
| Funding Rounds | 3 | 17 |
| Services | ||
| Services | Not tracked yet | AI-based drug discovery and development, Clinical trial management and execution, Partnerships for drug research and development, Data-driven insights and analytics for drug discovery |
| Target Customers | ||
| Target Customers | Not tracked yet | Pharmaceutical companies, Biotech firms, Healthcare institutions, Life sciences researchers, Oncology specialists |
| Taxonomy | ||
| Taxonomy | Drug Discovery, Drug Development, Therapeutic Areas, Automated Technologies, Pathway-based, Biology, Chemistry, Informatics, Integrated Technologies, Comprehensive Services | TechBio, Decoding Biology, Recursion OS, Drug Discovery, Biological And Chemical Datasets, Phenomics, Clinical-stage Biotechnology, Drug Repurposing, Immuno-oncology, Diseases Of Aging, Supercomputing |
| Website | ||
| Website | kalypsys.com | recursion.com |
About Kalypsys
Kalypsys is a biotechnology company founded in 2001 that is focused on shaping the future of medicine through comprehensive, automated drug discovery and development services across multiple therapeutic areas. The company's slogan reflects its commitment to leveraging pathway-based drug discovery an...
About Recursion
Recursion (NASDAQ: RXRX) is at the forefront of the TechBio sector, leveraging its platform, Recursion OS, to harness advanced AI and machine learning in pursuit of transforming medicine. Founded in 2013 and headquartered in the United States, Recursion is ambitiously decoding biology with the aim o...
We will tell you when either one moves
BounceWatch watches Kalypsys and Recursion for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Kalypsys and Recursion — by email.
Frequently Asked Questions
Compare Kalypsys with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Kalypsys on 11 Sep 2024, and Recursion on 23 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
